Abecomotide(907596-50-3)
- Name: Abecomotide
- Synonyms:Abecomotide;Abecomotide [INN];Abecomotide [WHO-DD];907596-50-3;Lys-thr-val-asn-glu-leu-gln-asn-leu;UNII-1003RM119S;1003RM119S;Abecomotide [INN:WHO-DD];Human insulin-like growth factor 2 mrna-binding protein 3 (imp-3, hkoc)-(508-513)-peptide;L-Leucine, L-lysyl-L-threonyl-L-valyl-L-asparaginyl-L-alpha-glutamyl-L-leucyl-L-glutaminyl-L-asparaginyl-;(2S,5S,8S,11S,14S)-14-((S)-4-amino-2-((S)-2-((2S,3R)-2-((S)-2,6-diaminohexanamido)-3-hydroxybutanamido)-3-methylbutanamido)-4-oxobutanamido)-5-(2-amino-2-oxoethyl)-8-(3-amino-3-oxopropyl)-2,11-diisobutyl-4,7,10,13-tetraoxo-3,6,9,12-tetraazaheptadecanedioic acid;HY-P2006;CS-0106960;Q27251089;(2S)-2-[[(2S)-4-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-hydroxybutanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]-4-carboxybutanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-oxobutanoyl]amino]-4-methylpentanoic acid;L-LEUCINE, L-LYSYL-L-THREONYL-L-VALYL-L-ASPARAGINYL-L-.ALPHA.-GLUTAMYL-L-LEUCYL-L-GLUTAMINYL-L-ASPARAGINYL-
- Molecular Formula:C45H79N13O16
- Molecular Weight:1058.2
- CAS Registry Number:907596-50-3
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 871502-18-0/6-(3,5-dimethyl-1H-pyrazol-1-yl)-2-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]pyridazin-3(2H)-one
- 892871-91-9/4Ata8SF635
- 302556-51-0/1-Methyl-3-(9-propan-2-yl-5,6,7,8-tetrahydrocarbazol-3-yl)-1-(2-pyridin-4-ylethyl)urea
- 810678-92-3/1-(3,5-dichlorophenyl)-3-[2-(2H-tetrazol-5-yl)-4-[3-(trifluoromethyl)phenyl]phenyl]urea
- 119188-99-7/2-[(3-aminopropyl)amino]-9,10-Anthracenedione
- 885051-45-6/Cetyltrimethylammonium 5-aminosulfonyl-4-chloro-2-[(2-furanylmethyl)amino]benzoate
- 873802-45-0/Ceramide 7
- 887626-22-4/4-chloro-6-(trifluoromethyl)pyrimidine-5-carboxylic Acid
- 869542-44-9/5-(2-Propen-1-yl)-2-[tris(1-methylethyl)silyl]oxazole
- 895131-40-5/2-(hydroxymethyl)-N-[2-(4-methylphenyl)ethyl]-1,3-benzothiazole-5-carboxamide
- 896722-43-3/(6-Methoxy-1-indolizinyl)(3,4,5-trimethoxyphenyl)methanone
- 676352-74-2/2H-1,2,4-Benzothiadiazine-3-acetic acid, 2-(3-butoxypropyl)-, ethyl ester, 1,1-dioxide
- 871362-32-2/2-Chloro-4-[2-[2,5-dimethyl-1-[3-(trifluoromethoxy)phenyl]imidazol-4-yl]ethynyl]pyridine
- 869376-64-7/11-(3-hydroxy-5-pentylphenoxy)-N-(4-hydroxyphenyl)undecanamide
- 892569-73-2/2,3:5,9-Dianhydro-4-deoxy-3-C-[(2S)-2-[[(1,1-dimethylethoxy)carbonyl]amino]-3-methoxy-3-oxopropyl]-7,8-O-(1-methylethylidene)-D-erythro-D-galacto-nonitol
- 873061-80-4/Ganoderone C
- 872715-18-9/N-[[(3S)-1-[2-(3-Chloro-6-methoxy-1,5-naphthyridin-4-yl)ethyl]-3-pyrrolidinyl]methyl][1,3]oxathiolo[5,4-c]pyridine-6-methanamine
- 881179-04-0/4-[[(3R,5R,8R,9S,10S,13R,14S,17R)-17-[(2R)-5-(carboxymethylamino)-5-oxopentan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-oxobutanoic acid
- 162854-81-1/Dup7T3BT69
- 907596-50-3/Abecomotide
- 19114-55-7/Titanium silicon oxide
- 744954-43-6/alpha,3-Dihydroxybenzenemethanesulfonic acid
- 896138-40-2/Flt-3 Inhibitor II
- 1800302-51-5/1-Piperidinecarboxylic acid, 4-[(2-cyanophenyl)methyl]-, 1,1-dimethylethyl ester
- 887611-92-9/(6-Fluoro-10-prop-2-enyl-9-tricyclo[9.4.0.03,8]pentadeca-1(15),3(8),4,6,9,11,13-heptaenyl) acetate
- 1538531-61-1/3U5Czs4zjr
- 213833-20-6/Acetyl L-carnitine taurinate
- 903528-74-5/Cumi-101 C-11
- 21873-55-2/N-[3-(quinoline-2-carbonylamino)propyl]quinoline-2-carboxamide
- 871656-65-4/Wvg4bzb398